SPARK Biopharma

Korea - SeoulPharmaceutical2 H-1B visas (FY2023)

Focus: SPARK Biopharma is a Korea-based pharmaceutical company focused on small molecule development across rare diseases, neurology, ophthalmology, oncology, and respiratory indications. Limited public data constrains assessment of market position and scale.

Rare Diseases Neurology Ophthalmology Oncology

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About SPARK Biopharma

AI assessmentNot Hiring

No open roles listed right now. Follow SPARK Biopharma to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Individually Tailored Perioperative Psychological Intervention

Breast Cancer

N/A

Clinical Trials (1)

NCT07510997Perioperative Individually Tailored Psychological Intervention in Breast Cancer Surgery

N/A

Help build intelligence for SPARK Biopharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diversified pipeline across 5 therapeutic areas with rare disease focus—rare disease drug development offers regulatory incentives and smaller, underserved markets
Multiple modalities in development including gene therapies (AAV platforms for hemophilia and retinal dystrophy) and novel mechanisms (neurostimulation for opioid use disorder)
Early-stage company positioning at Phase 3 inflection points suggests potential for rapid clinical advancement and career acceleration in a leaner organization

Watch Out For

Zero active job openings and lack of public hiring data indicates either minimal growth or potential hiring freeze—visibility into organizational scaling is absent
Portfolio exhibits concerning fragmentation with 30 disparate programs including non-drug assets (smartwatches, diagnostic questionnaires, temperature monitors) suggesting unfocused R&D strategy
H1B visa sponsorship is minimal (2 approvals, 1 denial in 2023) and restricted to Korean headquarters; international talent recruitment appears limited
No published financial, revenue, or funding data available—impossible to assess company stability, cash runway, or ability to fund pipeline through development

Generated by Claude from SPARK Biopharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Sparrow Link

Mental Fatigue

N/A

Clinical Trials (1)

NCT07109349tAN for First Responders

N/A

Volta System

Hemostasis

N/A

Clinical Trials (1)

NCT05977946Delivering Transcutaneous Auricular Neurostimulation to Regulate Platelet Activity in Healthy Human Subjects

N/A

Standard of Care FVIII Replacement therapy

Blood Coagulation Disorder

N/A

Clinical Trials (1)

NCT03876301Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

N/A

Volta tAN System

Blood Loss, Surgical

N/A

Clinical Trials (1)

NCT06647017Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

N/A

Sparrow Hawk

Acute Stress Reaction

N/A

Clinical Trials (1)

NCT06390267Effect of Transcutaneous Auricular Neurostimulation on Cognitive Performance in a Laboratory Model of Acute Stress Reaction

N/A

AAV2-hRPE65v2

Inherited Retinal Dystrophy Due to RPE65 Mutations

N/A

Clinical Trials (1)

NCT03602820Long-term Follow-up Study in Subjects Who Received Voretigene Neparvovec-rzyl (AAV2-hRPE65v2)

N/A

Sparrow Ascent tAN

Posttraumatic Stress Disorder

N/A

Clinical Trials (1)

NCT06130501tAN for PTSD and OUD in Buprenorphine Therapy

N/A

EEG Diagnostic for Repetitive Sub-concussive Head Impacts

Concussion

N/A

Clinical Trials (1)

NCT05562544EEG Diagnostic for Repetitive Sub-concussive Head Impacts

N/A

AAV2-hRPE65v2,voretigene neparvovec-rzyl

Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy

N/A

Clinical Trials (1)

NCT03597399A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

N/A

SPARK Test

Alzheimer Disease

N/A

Clinical Trials (1)

NCT05406778The REMIND Study- SPARK Neuro Software Study

N/A

TempTraq

Hematologic Malignancy

N/A

Clinical Trials (1)

NCT06415656VitalTraq for the Detection of CRS

N/A

Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).

Soft Tissue Infections

N/A

Clinical Trials (1)

NCT01790698Systems Medicine to Study Necrotizing Soft Tissue Infections (NSTIs).

N/A

Active Neurostimulation

Healthy

N/A

Clinical Trials (1)

NCT06782360Cognitive Augmentation Via Multimodal Sensing and Auricular Neurostimulation

N/A

Development of an EEG Diagnostic for Alzheimer's Disease

Mild Cognitive Impairment

N/A

Clinical Trials (1)

NCT04954183Development of an EEG Diagnostic for Alzheimer's Disease

N/A

Clinical Outcomes and Questionnaires

Opioid Use Disorder

N/A

Clinical Trials (1)

NCT05591703Clinical Outcomes Following Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention: A Long-term Follow-up Study

N/A

Sparrow Fledging Therapy System

Neonatal Opioid Withdrawal Syndrome

N/A

Clinical Trials (1)

NCT05129020Neurostimulation to Improve NOWS Outcomes

N/A

HCFWO

Chronic Obstructive Pulmonary Disease

N/A

Clinical Trials (1)

NCT04654481Study of AffloVest in At-Risk Respiratory Patients During COVID-19 Pandemic

N/A

Sparrow Ascent

Alcohol Use Disorder

N/A

Clinical Trials (1)

NCT07281261tAN for Substance Use Disorder

N/A

Spark Biomedical Roo Transcutaneous Auricular Neurostimulation

Neonatal Abstinence Syndrome

N/A

Clinical Trials (1)

NCT04588519tAN to Mitigate Withdrawal Behaviors in Neonates

N/A

Neutralizing Antibody to SPK-3006 capsid

Pompe Disease

N/A

Clinical Trials (1)

NCT03893240Neutralizing Antibody Seroprevalence Study With a Retrospective Component in Participants With Late-Onset Pompe Disease

N/A

LTFU for Gene Transfer Subjects With Hemophilia B

Hemophilia B

N/A

Clinical Trials (1)

NCT00515710LTFU for Gene Transfer Subjects With Hemophilia B

N/A

SPARK Cognitive Status Indicator

Alzheimer Disease

N/A

Clinical Trials (1)

NCT06809725Software Validation Study-Cognitive Status Indicator

N/A

Sparrow Therapy System

Opioid-use Disorder

N/A

Clinical Trials (1)

NCT04731935Novel Earpiece for Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

N/A

TempTraq

Temperature

N/A

Clinical Trials (1)

NCT03264833Accuracy and Precision Comparison of Temptraq

N/A

Volta System

Heavy Menstrual Bleeding

N/A

Clinical Trials (1)

NCT06814028Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial

N/A

Sparrow Link

Heavy Menstrual Bleeding

N/A

EmbracePlus Smartwatch

Opioid Withdrawal

N/A

Clinical Trials (1)

NCT06487533Sensing Physiological Symptoms of Opioid Withdrawal and Cravings in Patients With Opioid Use Disorder

N/A

transcutaneous auricular neurostimulation

Opioid-use Disorder

N/A

Clinical Trials (1)

NCT04075214Transcutaneous Auricular Neurostimulation (tAN) for Symptoms of Opioid Withdrawal

N/A

Volta System

Von Willebrand Disease, Type 1

N/A

Clinical Trials (1)

NCT06064851Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Patients With and Without Von Willebrand Disease

N/A

Sparrow Ascent Therapy System

Opioid-use Disorder

N/A

Clinical Trials (1)

NCT05053503Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder

N/A

SPK-8011

Hemophilia A

N/A

Clinical Trials (1)

NCT03432520Long-Term Safety and Efficacy of Spark-Sponsored Gene Therapies in Males With Hemophilia A